Increases in sympathetic activity and/or expression of α2-adrenergic receptors in the β cell likely exaggerate the antagonistic interaction of the α2-adrenergic signaling system with the GLP-1 signaling system in the pancreatic β cell to provoke and aggravate diabetes [35–39]. Here, GLP1R is linked to diabetes mellitus.